✦ LIBER ✦

P-789 Phase II study of OSI-211 (liposomal lurtotecan) in recurrentsmall-cell lung cancer (SCLC)

✍ Scribed by Ranson, M.; Dobbs, T.; Modiano, M.; Nicolson, M.; Fyfe, D.; Harper, P.; Sandler, A.; Cameron, T.; Ptaszynski, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of liposomal lurtotecan

✍ Michael V Seiden; Franco Muggia; Allan Astrow; Ursula Matulonis; Susanna Campos; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Phase II study of OSI-211 (liposomal lur

✍ F. Duffaud; M. Borner; P. Chollet; J.B. Vermorken; J. Bloch; M. Degardin; F. Rol 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 248 KB

36 P A phase II study of epirubicin in c

✍ D. Damianov; Sv. Hristova; I. Trifonova; G. Kurteva 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 162 KB

P-363 A phase II study of carboplatin/et

✍ James, Lindsay E.; Lee, Siow Ming 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

84 Phase II study of topotecan in refrac

✍ A. Ardizzoni; H.H. Hansen; P. Dombernowsky; S. Kaplan; P.E. Postmus; T. Gamucci; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase II study of carboplatin (AUC 5) an

✍ Dunlop, D.J; O'Brien, M; Lee, S; Hill, S; Thatcher, N 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 226 KB